The extracellular domain of CD4 receptor possesses a protein kinase activity  by Yakubov, Leonid A. et al.
The extracellular domain of CD4 receptor possesses a protein kinase
activity
Leonid A. Yakubova;b;*, Yury Y. Kita, Vladimir A. Richtera, Anna Y. Andreevaa,
Valery N. Karamysheva, C.A. Steinb, Valentin V. Vlassova
aNovosibirsk Institute of Bioorganic Chemistry, Siberian Division of Russian Academy of Sciences, 8 Lavrentiev Ave., Novosibirsk 630090, Russia
bColumbia University 630 W. 168 St., New York, NY 10032, USA
Received 18 May 1998; revised version received 4 June 1998
Abstract The CD4 receptor of T-helper cells is an essential
participant in immune response formation and HIV infection. We
report here that the extracellular domains of CD4 receptor can
catalyze the phosphotransferase (kinase) reaction. Incubation of
rsCD4 in solution with [Q-32P]ATP results in the Ca2+-dependent
autophosphorylation of the protein presumably at a His residue
because the reaction is prevented by the diethylpyrocarbonate
treatment. The rsCD4 phosphorylates milk casein or human
plasma proteins as a Ser/Thr protein kinase.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
CD4, a cell surface transmembrane glycoprotein of T-helper
cells, participates in several cellular processes and interactions,
including T cell receptor (TCR)/CD3-mediated recognition of
processed antigen/MHC (major histocompatibility complex)
class II complexes on the surface of B lymphocytes and other
antigen presenting cells (APC). This leads to stimulation of
lymphocytes and to humoral immune responses [1^3]. The
interaction of CD4 accessory molecules on T cells with
MHC class II antigens on B cells is also essential for T cell
activation [4^6]. Direct binding of the CD4 receptor with an
invariant domain of the MHC class II molecules has been
shown to facilitate and augment T cell adhesion to APC
[7,8]. In addition, adhesion of T-cells to extracellular matrix
proteins is a CD4-regulated process which requires activation
by a peptide antigen or mitogen [9^11].
CD4 is also a major receptor protein for the HIV envelope
glycoprotein gp120 [12]. E⁄cient entry of HIV-1 into target
cells also requires the chemokine receptors, CCR-5 and
CXCR-4, whose interaction with gp120 leads ultimately to
viral and cellular membrane fusion [13]. Indeed, binding of
CD4 to gp120 greatly increases the e⁄ciency of the gp120-
CCR5 interaction, and there is evidence for a physical asso-
ciation between CXCR4 and the CD4-gp120 complex on the
cell membrane [14^16]. This association is followed by pro-
ductive HIV infection in T-cells.
We earlier investigated the interaction of the CD4 receptor
with phosphodiester and phosphorothioate oligodeoxynucleo-
tides and we found that oligonucleotides bind to the receptor
and interfere with the CD4-gp120 interaction [17]. This in part
accounts for the sequence independent anti-HIV activity of
oligonucleotides. We have also recently described the ability
of CD4, in the presence of [Q-32P]ATP during incubation with
human plasma, to undergo phosphorylation at serine and
threonine residues [18]. In this paper we report that the ex-
tracellular CD4 domain displays a protein kinase activity.
2. Materials and methods
2.1. Materials
Electrophoretic reagents were purchased from Sigma, and molecu-
lar weight markers from Sigma and Amersham. Dephosphorylated
bovine milk caseins were obtained from Sigma and Merck. [Q-32P]ATP
and cold ATP were from Amersham. Chemicals were from Sigma,
Aldrich and Fluka.
2.2. Recombinant proteins
The investigation of putative kinase activity of the CD4 receptor
was performed using a recombinant extracellular soluble fragment of
human CD4 (rsCD4, amino acids 1^362) from Genentech Co. The
main experiments on autophosphorylation and on the phosphoryla-
tion of casein were reproduced with two rsCD4 samples from Phar-
macia-Upjohn and Biogen, with identical results.
2.3. Autophosphorylation of rsCD4
1.5 Wg of rsCD4 was incubated with 0.1 mCi of [Q-32P]ATP in 10 Wl
of 0.05 M Tris-HCl bu¡er, pH 7.4, at 37‡C for 30 min in the absence
or presence of 10 mM of divalent cations as chlorides and potential
competitors of autophosphorylation (Fig. 1A,B), or 5 Wg of rsCD4
were incubated in 10 Wl of 150 mM NaCl, 10 mM Tris-HCl, pH
7.4, 1 mM CaCl2 and 0.5 mM MgCl2 with 50 WCi [Q-32P]ATP or
[K-32P]ATP, where indicated (Fig. 1C).
2.4. Phosphorylation of substrates
Human plasma was prepared in citrate bu¡er according to [19].
10 Wl of the prepared plasma was incubated with 0.1 mCi [Q-32P]ATP
with and without rsCD4. Bovine milk casein, 10 Wg and 5 Wg of
rsCD4 were incubated with 0.05 mCi [Q-32P]ATP in 10 Wl of 10 mM
Tris-HCl, pH 7.4, in di¡erent salt conditions as indicated in the legend
to Fig. 2. After 15 min incubation at 23‡C, the reaction was termi-
nated by addition of equal volumes of 20% TCA. The precipitates
were washed with acetone and dissolved in 50 mM Tris-HCl bu¡er,
pH 6.8, containing 2% SDS, 2% 2-mercaptoethanol and 20% glycerol.
The proteins were analyzed by SDS-electrophoresis.
2.5. Phosphoroamino acid analysis
Two dimensional separation of amino acids of acid hydrolysate of
the phosphorylated casein was performed on cellulose TLC plates
(Kodak). First direction: electrophoresis (acetic acid/pyridine/water,
87:2:911); second direction: chromatography (n-butanol/formic
acid/water, 4:1:1) [20].
2.6. Treatment of rsCD4 with diethylpyrocarbonate
5 Wg CD4 in 10 Wl of 20 mM MOPS bu¡er, pH 7.0, was incubated
for 2 h at 25‡C with 0, 1, 5, 10 and 20 mM diethylpyrocarbonate, then
Tris-HCl, pH 7.4, was added to a ¢nal concentration of 20 mM and
incubated for 20 min, then 30 WCi of [Q-32P]ATP in 1 Wl was added to
the samples with and without 10 Wg of casein and they were incubated
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another 20 min at 25‡C. E¡ect on the phosphorylation activity was
observed after SDS-PAGE and autoradiography.
2.7. Isolation of autophosphorylated CD4
50 Wg rsCD4 and 150 WCi of [Q-32P]ATP were incubated in 30 Wl of
20 mM Tris-HCl, pH 7.4, 1 mM CaCl2, 0.5 mM MgCl2, 70 mM NaCl
for 20 min at 37‡C and then loaded on a gel ¢ltration column (TSK
HW40 Fractogel, Merck, exclusion limit 10 kDa) with a total volume
of 250 Wl (free vol. about 75 Wl). The column was equilibrated with the
same bu¡er as the incubation medium. All 30-Wl fractions eluted from
the column were collected and the ¢rst ¢ve fractions were analyzed by
incubation in the elution bu¡er with 15 Wg of casein for 30 min at
37‡C and separated by SDS-electrophoresis. Maximum radioactivity
corresponding to free ATP was eluted in fraction N7.
2.8. A⁄nity labeling of rsCD4 with alkylating, radiolabeled ATP
derivative (ClRNH-*pppA)
4-(N-2-Chloroethyl-N-methyl)aminobenzylamine (ClRNH2) was
coupled to Q-phosphate of [Q-32P]ATP in organic solution by reaction
with triphenylphosphine/dipyridyl disul¢de as previously described
[21]. Alkylating grouping ClRNH2 was synthesized in NIBC (Novo-
sibirsk) by Dr. Tamara M. Ivanova. 1 Wg of rsCD4 was incubated in
20 Wl of 20 mM Tris-HCl, pH 7.4, 0.5 M NaCl, 1 mM CaCl2, 0.5 mM
MgCl2 for 40 min at 37‡C with increasing concentrations of the al-
kylating radiolabeled reagent (see Fig. 6).
2.9. SDS-PAGE
Typically 5 Wl of 2% SDS, 2% mercaptoethanol, 30% glycerol was
added to each 10-Wl probe, and the probes were heated in a boiling
water bath for 1 min. Then the samples were resolved by SDS-electro-
phoresis in 12% polyacrylamide; the gels were dried and autoradio-
graphed.
3. Results and discussion
3.1. Autophosphorylation of rsCD4
Fig. 1A shows the results of incubation of rsCD4 with
[Q-32P]ATP in the presence of di¡erent divalent cations which
indicate that the protein undergoes autophosphorylation in
the experimental conditions. The e⁄ciency of the process
was similar in the absence of added cations, in 10 mM
EDTA and in the presence of 10 mM Mg2, Mn2, Cu2
and Co2 ions. Ca2 and, to a lesser extent, Zn2 and Ni2,
stimulate autophosphorylation considerably. Fig. 1B demon-
strates the e¡ect of some potential substrates and inhibitors
(di¡erent oligodeoxynucleotides and anionic dyes) on the ra-
diolabeling of rsCD4 in the presence of [Q-32P]ATP and Ca2.
Earlier we found that the CD4 molecule possesses two remote
polyanion binding sites, and that the oligodeoxynucleotides
longer than 15-mers are capable of spanning the distance be-
tween these sites. Both these sites are localized at the amino-
terminal domain of the receptor [22,23]. The phosphoro-
thioate oligonucleotide analog SdC28, which displays maxi-
mal a⁄nity for the protein (Kd=3 nM) [21], causes maximal
inhibition of the protein autophosphorylation (Fig. 1B). Only
partial inhibition of autophosphorylation was observed in the
presence of the phosphodiester oligodeoxynucleotide pT16
and Active red III dye, the compounds that display a lower
a⁄nity for CD4 than the phosphorothioate oligodeoxynucleo-
tide [23,24]. These observations suggest that the phosphoryla-
tion activity is localized near the amino-terminal domain of
the molecule. We also evaluated mouse IgG as potential in-
hibitor or substrate of the phosphorylation process (Fig. 1B,
lane 1). Total mouse IgG (1 mg/ml) did not a¡ect the auto-
phosphorylation of CD4, and also was not itself phosphoryl-
ated.
Pre-heating of the CD4 in solution at 65‡C for 10 min
abolishes the formation of radiolabeled products upon incu-
bation with [Q-32P]ATP (Fig. 1C, compare lanes 1 and 2). The
process of formation of the 32P-labeled rsCD4 can still occur
to some extent even at 4‡C (Fig. 1C, lane 3). Addition of
excess cold ATP to the reaction mixture inhibits the labeling
of the CD4, but addition of the same excess of cold ATP
to the mixture after the labeling procedure does not alter
the quantity of labeled protein. Finally, substitution of
[K-32P]ATP for the [Q-32P]ATP in the reaction mixture abol-
ishes the radiolabeling process (compare lanes 1 and 6 in Fig.
1C), demonstrating that covalently bound Q-phosphate of
ATP is responsible for the labeling.
3.2. Phosphorylation of substrates by rsCD4
We then investigated phosphorylation of human plasma
proteins in the presence of rsCD4 and [Q-32P]ATP (Fig. 2).
No protein radiolabeling can be observed in citrate bu¡ered
human plasma incubated with [Q-32P]ATP alone (lane 1). Ad-
dition of rsCD4 causes incorporation of the radiolabel into
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Fig. 1. E¡ect of some metal ions and potential inhibitors on the au-
tophosphorylation of rsCD4. rsCD4 was incubated with [Q-32P]ATP
in the presence of di¡erent additives. A: E¡ect of divalent cations.
Lane 1: no additions; lanes 2^9, 10 mM Mg2, Mn2, Ca2, Cu2,
Ni2, Zn2, Co2 and EDTA, respectively. B: E¡ect of potential in-
hibitors. Lane 1: total mouse IgG (0.3 mg/ml); lane 2: STD, no
competitors; lane 3: phosphorothioate oligonucleotide SdC28
(17 WM); lane 4: Active red III dye (17 WM); lane 5: phosphodiest-
er oligonucleotide pT16 (17 WM). C: Autophosphorylation in some
speci¢c conditions. Lane 1: 20 min, 25‡C; lane 2: the same as lane
1, but CD4 was preheated for 10 min at 65‡C; lane 3: 20 min,
4‡C; lane 4: the same as lane 1 but with addition of 3 mM of cold
ATP; lane 5: the same as lane 1 but 3 mM of unlabeled ATP were
added after 20 min of incubation; lane 6: with [K-32P]ATP under
the conditions as in sample 1. SDS electrophoresis, autoradio-
graphy.
Fig. 2. Phosphorylation of substrates catalyzed by rsCD4. Lane 1:
human plasma alone; lane 2: human plasma with rsCD4; lane 3:
rsCD4 alone. Lanes 4^7: milk casein with rsCD4 in 10 mM MgCl2
(lane 4); 10 mM CaCl2 (lane 5); 10 mM MgCl2, 150 mM NaCl
(lane 6); 10 mM CaCl2, 150 mM NaCl (lane 7). Samples were pre-
cipitated with trichloroacetic acid after incubation. For conditions
see Section 2. SDS-electrophoresis, autoradiography.
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plasma proteins with molecular masses of 68 kDa and 12 kDa
(lane 2). In this experiment, the samples were concentrated
with 20% trichloroacetic (TCA) acid before electrophoresis.
However, this treatment resulted, surprisingly, in elimination
of the label from the autophosphorylated CD4 (lane 3) but
not from the labeled plasma proteins (lane 2) suggesting acid
lability of the [32P]-CD4 bond. The e¡ect of TCA precipita-
tion on CD4 and substrate casein is also seen in Fig. 4 (com-
pares lanes 1P at upper and lower panels).
Incubation of rsCD4 and ATP in the presence of dephos-
phorylated bovine milk casein, a classic substrate for kinase
reactions, leads to incorporation of the label into the protein,
with formation of an acid-resistant phosphorylation product
(Fig. 2). While the presence of Ca2 is required for the for-
mation of the acid-labile complex of [32P]phosphate with
CD4, phosphorylation of casein occurs e⁄ciently in the pres-
ence of Mg2 at lower ionic strength. At physiologic salt
concentration, however, Ca2 supports the kinase reaction
better than Mg2. This dependence on the ionic composition
of the bu¡er of the rsCD4-catalyzed kinase reaction may play
a regulatory role in CD4 protein kinase functioning.
3.3. Amino acid phosphorylation speci¢city
Only [32P]phosphoserine (Fig. 3) was detected by phos-
phoroamino acid analysis [20] after the acidic hydrolysis of
the phosphorylated casein. However, analysis of autophos-
phorylated CD4 detected no phosphoroamino acids in the
acidic hydrolysate, which further demonstrates the acid-labil-
ity of the [32P]-CD4 bond, thus suggesting that phosphate
either forms a phosphoramidate bond with amino groups of
lysine, histidine or arginine or it forms acyl-phosphate deriv-
atives with acidic amino acids. These types of bonds are gen-
erally assumed for phosphorylated intermediates in enzymatic
mechanisms [25]. The autophosphorylation activity yielding
acid labile product is associated with participation of His or
Tyr residues, because pretreatment of CD4 with diethylpyro-
carbonate, a known His and Tyr modi¢er, inhibits the activity
at all concentrations tested. At the same time this reagent even
increases the phosphorylation of casein at some concentra-
tions (lanes 3P and 4P). This means that only His, which forms
an acid labile bond with phosphate, may be involved in au-
tophosphorylation as phosphate acceptor, and that phospho-
rylation of substrate (casein) is likely to be independent of this
(autophosphorylation) process. Moreover, the autophospho-
rylation of CD4 can be inhibited to some extent by the pres-
ence of substrate casein (compare lanes 1 and 1P at the lower
panel of Fig. 4). This suggests that the same kinase activity in
CD4 molecule may transfer phosphate to its own His or to
Ser of substrate and provide both autophosphorylation and
phosphorylation processes. Increase in phosphorylation of ca-
sein at medium concentration of diethylpyrocarbonate can be
explained by the fact that the autophosphorylation reaction is
abolished by the His modi¢cation and all phosphates bound
by the enzyme are used for substrate phosphorylation.
3.4. Possible function of autophosphorylated CD4
We isolated the autophosphorylated labeled CD4 from the
reaction mixture using Toyopearl gel ¢ltration media. Then,
we found that this 32P-labeled protein which is free of
[32P]ATP can phosphorylate substrate casein apparently using
the [32P]phosphate incorporated into the protein during auto-
phosphorylation (Fig. 5). It is most likely that the protein has
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Fig. 5. Phosphorylation of casein by autophosphorylated CD4 in
the absence of free ATP. Autophosphorylated CD4 was isolated
from reaction medium by gel chromatography (lane numbers corre-
spond to the numbers of chromatographic fractions) and the frac-
tions were incubated with milk casein for 30 min. Left panel (lanes
1^5) is autoradiographed and right panel (lanes 1P^5P) is the corre-
sponding Coomassie stained gel.
Fig. 4. E¡ect of diethylpyrocarbonate on phosphorylation activity
of rsCD4. Samples 1^5: CD4 was treated with 0, 1, 5, 10, 20 mM
diethylpyrocarbonate and then incubated with [Q-32P]ATP (auto-
phosphorylation). Samples 1P^5P : the same as 1^5 except that casein
was added to the samples together with [32P]ATP. The upper and
lower panels correspond to two almost identical experiments with
the di¡erence that samples 1P^5P on the upper panel were precipi-
tated with trichloroacetic acid, whereas those at the lower panel
were not. SDS-electrophoresis and autoradiography.
Fig. 3. Amino acid speci¢city of the phosphorylation of casein with
rsCD4 and [Q-32P]ATP (autoradiography).
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a capacity to accept phosphate for future phosphorylation of
biological targets.
3.5. Identi¢cation of ATP binding site in rsCD4
We found that the alkylating 32P derivative of ATP, bearing
RCl, 4-(N-2-chloroethyl-N-methyl)aminobenzylamine at the Q-
phosphate, forms covalent conjugates with rsCD4 in a con-
centration dependent manner and that the cold ATP competes
with this process (Fig. 6). A⁄nity of the reactive ATP analog
for the CD4 molecule was estimated from the isotherm of
chemical modi¢cation according to [23] by Kd V3 WM. Dis-
sociation constant for cold ATP determined in competition
experiment in this a⁄nity labeling reaction according to
[22,23] was close to that of the alkylating ATP derivative.
3.6. Homology of CD4 primary structure with protein kinase
sequences
Our extensive attempts to ¢nd similar regions in the pri-
mary sequences of the extracellular domain of the CD4 pro-
tein and various protein kinases available from GenBank [26]
failed. No homology was detected with near-optimal align-
ment tools [27], or by a search for protein kinase ‘signatures’
stored in the PROSITE database [28]. However, we found a
weak similarity of the CD4 extracellular domain with myosin
light chain kinase sequences (chicken) by means of dot-blot
analysis and BLAST searches [29]. Yet we could ¢nd no sim-
ilarities with the known ATP binding sites. Therefore we as-
sumed that the kinase activities of ‘conventional’ serine-threo-
nine protein kinases and that of the CD4 protein were
associated with non-homologous protein structures.
The present study demonstrates that rsCD4 can be auto-
phosphorylated using Q-phosphate of ATP which forms an
acid-labile bond with the receptor, probably via His residue.
This activity is localized at or near the amino-terminal domain
of CD4. The receptor also catalyzes the kinase reaction for
casein and blood proteins as a serine/threonine protein kinase.
The autophosphorylated CD4 is able to phosphorylate sub-
strate in the absence of ATP in solution operating as a loaded
crossbow lying in wait for its target. This protein kinase
clearly requires extracellular ATP for its activity. Extracellular
ATP is, in fact, necessary for the functioning of T-helper and
cytotoxic T-lymphocytes [30]. Moreover an inhibitor of Ser/
Thr phosphatase enhances cytolytic T-lymphocyte-mediated
cytotoxicity [31]. Thus the CD4 kinase activity may be asso-
ciated with numerous intermolecular interactions of this mol-
ecule.
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Fig. 6. A⁄nity labeling of rsCD4 by alkylating ATP derivative.
Competition with cold ATP. rsCD4 was incubated with the alkylat-
ing radiolabeled reagent ClR-*pppA 0.5, 1, 2.5, 5, 7.5, 10 WM (lanes
1^6, respectively), or with 5 WM of the reagent in the presence of 0,
1, 5, 10, 20 WM of cold ATP (lanes 7^11, respectively). SDS-electro-
phoresis, autoradiography.
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